IRIS Accounts Production v26.1.10.61 06632247 Board of Directors 1.4.25 31.3.26 31.3.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066322472025-03-31066322472026-03-31066322472025-04-012026-03-31066322472024-03-31066322472024-04-012025-03-31066322472025-03-3106632247ns15:EnglandWales2025-04-012026-03-3106632247ns14:PoundSterling2025-04-012026-03-3106632247ns10:Director12025-04-012026-03-3106632247ns10:PrivateLimitedCompanyLtd2025-04-012026-03-3106632247ns10:SmallEntities2025-04-012026-03-3106632247ns10:AuditExempt-NoAccountantsReport2025-04-012026-03-3106632247ns10:SmallCompaniesRegimeForDirectorsReport2025-04-012026-03-3106632247ns10:SmallCompaniesRegimeForAccounts2025-04-012026-03-3106632247ns10:FullAccounts2025-04-012026-03-3106632247ns10:Director22025-04-012026-03-3106632247ns10:Director32025-04-012026-03-3106632247ns10:Director42025-04-012026-03-3106632247ns10:Director52025-04-012026-03-3106632247ns10:Director62025-04-012026-03-3106632247ns10:RegisteredOffice2025-04-012026-03-3106632247ns5:CurrentFinancialInstruments2026-03-3106632247ns5:CurrentFinancialInstruments2025-03-3106632247ns5:Non-currentFinancialInstruments2026-03-3106632247ns5:Non-currentFinancialInstruments2025-03-3106632247ns5:ShareCapital2026-03-3106632247ns5:ShareCapital2025-03-3106632247ns5:CapitalRedemptionReserve2026-03-3106632247ns5:CapitalRedemptionReserve2025-03-3106632247ns5:RetainedEarningsAccumulatedLosses2026-03-3106632247ns5:RetainedEarningsAccumulatedLosses2025-03-3106632247ns5:FurnitureFittings2025-04-012026-03-3106632247ns5:MotorVehicles2025-04-012026-03-3106632247ns5:ComputerEquipment2025-04-012026-03-3106632247ns5:FurnitureFittings2025-03-3106632247ns5:MotorVehicles2025-03-3106632247ns5:ComputerEquipment2025-03-3106632247ns5:FurnitureFittings2026-03-3106632247ns5:MotorVehicles2026-03-3106632247ns5:ComputerEquipment2026-03-3106632247ns5:FurnitureFittings2025-03-3106632247ns5:MotorVehicles2025-03-3106632247ns5:ComputerEquipment2025-03-3106632247ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-03-3106632247ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-04-012026-03-3106632247ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2026-03-3106632247ns5:LeasedAssetsHeldAsLesseens5:MotorVehicles2025-03-3106632247ns5:WithinOneYearns5:CurrentFinancialInstruments2026-03-3106632247ns5:WithinOneYearns5:CurrentFinancialInstruments2025-03-3106632247ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:FinanceLeases2026-03-3106632247ns5:WithinOneYearns5:CurrentFinancialInstrumentsns5:FinanceLeases2025-03-3106632247ns5:FinanceLeasesns5:BetweenOneFiveYears2026-03-3106632247ns5:FinanceLeasesns5:BetweenOneFiveYears2025-03-3106632247ns5:FinanceLeases2026-03-3106632247ns5:FinanceLeases2025-03-3106632247ns5:WithinOneYear2026-03-3106632247ns5:WithinOneYear2025-03-3106632247ns5:BetweenOneFiveYears2026-03-3106632247ns5:BetweenOneFiveYears2025-03-3106632247ns5:AllPeriods2026-03-3106632247ns5:AllPeriods2025-03-31
REGISTERED NUMBER: 06632247 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2026

FOR

BRINK MEDICINES LIMITED

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BRINK MEDICINES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2026







DIRECTORS: Dr M S Sira
Dr A Culshaw
Dr T M Webster
Mrs J K Sira
Mrs L J Webster
A B Culshaw





REGISTERED OFFICE: 7 North Brink
Wisbech
Cambridgeshire
PE13 1JU





REGISTERED NUMBER: 06632247 (England and Wales)





ACCOUNTANTS: Wheelers
Chartered Accountants & Tax Consultants
27-29 Old Market
Wisbech
Cambridgeshire
PE13 1NE

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

BALANCE SHEET
31 MARCH 2026

31.3.26 31.3.25
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 17,382 23,008

CURRENT ASSETS
Stocks 69,215 47,592
Debtors 5 184,184 198,457
Cash at bank and in hand 256,543 211,341
509,942 457,390
CREDITORS
Amounts falling due within one year 6 215,422 206,964
NET CURRENT ASSETS 294,520 250,426
TOTAL ASSETS LESS CURRENT
LIABILITIES

311,902

273,434

CREDITORS
Amounts falling due after more than one
year

7

(10,467

)

(12,914

)

PROVISIONS FOR LIABILITIES (1,200 ) (1,500 )
NET ASSETS 300,235 259,020

CAPITAL AND RESERVES
Called up share capital 600 600
Capital redemption reserve 40 40
Retained earnings 299,595 258,380
SHAREHOLDERS' FUNDS 300,235 259,020

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2026.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2026 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

BALANCE SHEET - continued
31 MARCH 2026


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 27 October 2026 and were signed on its behalf by:





Dr M S Sira - Director


BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2026

1. STATUTORY INFORMATION

Brink Medicines Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The directors believe that the company is well placed to manage its financial risks successfully and have reasonable expectation that it has adequate resources to continue in operational existence for the foreseeable future. Consequently, it continues to adopt the going concern basis of accounting in preparing the annual financial statements.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Fixtures and fittings - 15% on reducing balance
Motor vehicles - 25% on reducing balance
Office equipment - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

2. ACCOUNTING POLICIES - continued

Hire purchase and leasing commitments
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 10 (2025 - 11 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and Motor Office
fittings vehicles equipment Totals
£    £    £    £   
COST
At 1 April 2025 23,661 19,709 15,342 58,712
Additions - - 320 320
At 31 March 2026 23,661 19,709 15,662 59,032
DEPRECIATION
At 1 April 2025 21,721 5,256 8,727 35,704
Charge for year 291 3,941 1,714 5,946
At 31 March 2026 22,012 9,197 10,441 41,650
NET BOOK VALUE
At 31 March 2026 1,649 10,512 5,221 17,382
At 31 March 2025 1,940 14,453 6,615 23,008

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

4. TANGIBLE FIXED ASSETS - continued

Fixed assets, included in the above, which are held under finance leases are as follows:
Motor
vehicles
£   
COST
At 1 April 2025
and 31 March 2026 19,709
DEPRECIATION
At 1 April 2025 5,256
Charge for year 3,941
At 31 March 2026 9,197
NET BOOK VALUE
At 31 March 2026 10,512
At 31 March 2025 14,453

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Trade debtors 151,048 152,649
Other debtors 33,136 45,808
184,184 198,457

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.26 31.3.25
£    £   
Finance leases (see note 8) 2,447 2,251
Trade creditors 110,453 120,731
Taxation and social security 56,533 38,125
Other creditors 45,989 45,857
215,422 206,964

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.26 31.3.25
£    £   
Finance leases (see note 8) 10,467 12,914

BRINK MEDICINES LIMITED (REGISTERED NUMBER: 06632247)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2026

8. LEASING AGREEMENTS

Minimum lease payments fall due as follows:

Finance leases
31.3.26 31.3.25
£    £   
Net obligations repayable:
Within one year 2,447 2,251
Between one and five years 10,467 12,914
12,914 15,165

Non-cancellable
operating leases
31.3.26 31.3.25
£    £   
Within one year 6,300 6,300
Between one and five years - 6,300
6,300 12,600

9. SECURED DEBTS

The following secured debts are included within creditors:

31.3.26 31.3.25
£    £   
Finance leases 12,914 15,165

The obligations under finance lease agreements are secured over the assets to which they relate.